# Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach

> **NCT03266965** · PHASE1 · COMPLETED · sponsor: **University of Miami** · enrollment: 18 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Carbidopa
- **DIETARY_SUPPLEMENT:** L-Histidine

## Key facts

- **NCT ID:** NCT03266965
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-23
- **Primary completion:** 2020-08-07
- **Final completion:** 2020-08-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03266965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03266965, "Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03266965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*